BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pharma Journalist - ECPv6.16.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.pharmajournalist.com
X-WR-CALDESC:Events for Pharma Journalist
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Asia/Kolkata
BEGIN:STANDARD
TZOFFSETFROM:+0530
TZOFFSETTO:+0530
TZNAME:IST
DTSTART:20180101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20190813
DTEND;VALUE=DATE:20190816
DTSTAMP:20260515T010010
CREATED:20190530T091644Z
LAST-MODIFIED:20190530T091644Z
UID:20938-1565654400-1565913599@www.pharmajournalist.com
SUMMARY:B3DD Summit
DESCRIPTION:The Blood-Brain Barrier Delivery Summit (B3DD) is the industry’s first conference dedicated to addressing the translational challenges of effective and safe delivery of CNS drug candidates. \n \nWith an emphasis on biologics\, and built with the field’s leading minds from the likes of Biogen\, Genentech\, Armagen & Denali\, the B3DD Summit will unite over 60 industry stakeholders giving you the opportunity to develop new partnerships and build on existing relationships to ensure you have the connections to accelerate your drug’s development. \nSome of the highlights include: \n\nAssessing Microphysiological Models of the BBB – Biogen\nEmploying in vivo Microdialysis & Microperfusion Methods to Understand Brain Disposition of Biologics for the Treatment of CNS Disorders – AbbVie\nClinical Efficacy of Antibody-enzyme Fusion Proteins as Carrier Platform to Transport Lysosomal Enzymes Across the BBB for the Treatment of Mucopolysaccharidosis Type I\nPKPD of Different Therapeutic Modalities for CNS Indications – Genentech\nExplaining Clinical Failures – Is Efficacy or Delivery to Blame?- Merck\, Lundbeck\, AbbVie\n\nTo learn more about B3DD Summit\, and to register online\, visit https://ter.li/7vs04e
URL:https://www.pharmajournalist.com/event/b3dd-summit/
LOCATION:Wyndham Boston Beacon Hill\, 5 Blossom St\, Boston\, MA\, 02114\, United States
ORGANIZER;CN="Hanson Wade":MAILTO:info@hansonwade.com
END:VEVENT
END:VCALENDAR